Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title FOA
Accordino, Melissa Columbia University Health Sciences Cryotherapy and Compression Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients PAR-18-021: NCI Small Grants Program for Cancer Research
Bao, Ting Sloan-Kettering Inst Can Research Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research
Bao, Ting Sloan-Kettering Inst Can Research Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research
Dougherty, Patrick M University Of Tx Md Anderson Can Ctr The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN PA-13-302: Research Project Grant
Gewandter, Jennifer University Of Rochester Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial PA-18-159: Mechanisms, Models, Measurement, and Management in Pain Research
Kolb, Noah Allan University Of Vermont & St Agric College Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Kroetz, Deanna L University Of California, San Francisco Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity PA-20-185: NIH Research Project Grant
Levine, Jon David University Of California, San Francisco Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
Lustberg, Maryam B Ohio State University Prevention of paclitaxel-induced peripheral neuropathy with nilotinib RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions
Melemedjian, Ohannes Kevork University Of Maryland Baltimore Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment
Romero-Sandoval, E. Alfonso Wake Forest University Health Sciences IRE1a-XBP1 Signaling as a Driver of Chemotherapy-Induced Peripheral Neuropathy PA-16-258: Mechanisms of Cancer and Treatment-related Symptoms and Toxicities
Salvemini, Daniela Saint Louis University A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity PAR-16-275: Serious Adverse Drug Reaction Research
Smith, Ellen Mary Lavoie University Of Michigan At Ann Arbor Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Staff, Nathan P Mayo Clinic Rochester Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology PA-16-160: NIH Research Project Grant
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program

Pages